i
Class I indication for low molecular weight heparin therapy in theilast 2-3 days before cardioversion:
- CHF + NYHA Class II - IV symptoms + AF requiring urgent cardioversion + patients who have not been treated with oral anticoagulant.
Class I indication for low molecular weight heparin therapy in the first 2-3 days after cardioversion:
- CHF + NYHA Class II - IV symptoms + AF undergoing effective urgent cardioversion + patients who have not been treated with oral anticoagulant.
i